Form 8-K - Current report:
SEC Accession No. 0000912282-17-000110
Filing Date
2017-05-09
Accepted
2017-05-09 16:32:26
Documents
1
Period of Report
2017-05-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 antriabio8k_050917.htm 8-K 25164
  Complete submission text file 0000912282-17-000110.txt   26398
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54495 | Film No.: 17826918
SIC: 2834 Pharmaceutical Preparations